Respiratory manifestations in HIV-infected children pre- and post-HAART in Abidjan, the Ivory Coast

Paediatric Respiratory Reviews

Volumn 5, Issue 4, 2004, Pages 311-315

  Kouakoussui, A ^a   Fassinou, P ^b   Anaky, M F ^a   Elenga, N ^a   Laguide, R ^a   Wemin, M L ^c   Toure, R ^d   Menan, H ^d   Rouet, F ^d   Msellati, Philippe ^e,f  

^a PACCI   (Côte d’Ivoire)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE YOPOUGON   (Côte d’Ivoire)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE TREICHVILLE   (Côte d’Ivoire)

^d CeDReS   (Côte d’Ivoire)

^e INSTITUT DE RECHERCHE POUR LE DÉVELOPPEMENT   (France)

^f Représentation IRD   (Côte d’Ivoire)

Author keywords

Africa; C te d'Ivoire; HAART; Paediatric HIV infection; Respiratory infections

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; COTRIMOXAZOLE; EFAVIRENZ; NELFINAVIR; TUBERCULOSTATIC AGENT;

ADOLESCENT; ANAMNESIS; BRONCHITIS; CHILD; CLINICAL FEATURE; CLINICAL OBSERVATION; COHORT ANALYSIS; CONTROLLED STUDY; COTE D'IVOIRE; FEMALE; FOLLOW UP; FRANCE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LOWER RESPIRATORY TRACT INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PNEUMOCYSTIS PNEUMONIA; PRESCRIPTION; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; THORAX RADIOGRAPHY; UPPER RESPIRATORY TRACT INFECTION; VIRUS LOAD;

EID: 7744240642     PISSN: 15260542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prrv.2004.07.008     Document Type: Article

References (20)

1. UNAIDS WHO. Report on the global HIV/AIDS epidemic. December 2002. http://www.unaids.org 38p
2. R. Spira P. Lepage P. Msellati et al. Natural history of Human Immunodeficiency Virus type 1 infection in children: A five-year prospective study in Rwanda Pediatrics 104 1999 56
3. T. Taha S. Graham N. Kumwenda et al. Morbidity among Human Immunodeficiency virus-infected and uninfected African children Pediatrics 106 2000 77
4. F. Dabis N. Elenga N. Meda et al. 18-Month mortality and perinatal exposure to zidovudine in West Africa AIDS 15 2001 771-779
5. P. Lepage P. Van de Perre G. van Vliet et al. Clinical and endocrinological manifestations in perinatally HIV-1 infected children aged five years or more Am J Dis Child 145 1991 1248-1251
6. Kabore A, Diagbouga S, Manigart O et al. Absence de progression clinique de l'infection par le VIH chez des enfants au Burkina Faso. Xllème Congrès International sur le SIDA et les Maladies sexuellement transmissibles en Afrique. Ouagadougou, Burkina Faso, 9-13 décembre 2001. Abstract.
7. K. Vetter G. Djomand F. Zadi et al. Clinical spectrum of human immunodeficiency virus disease in children in a West African city Pediatr Infect Dis J 15 1998 438-442
8. M. Badri D. Wilson R. Wood Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: A cohort study Lancet 359 2000 2059-2064
9. Fassinou P, Elenga N, Rouet F et al. Highly active antiretroviral therapies among HIV-1 infected children in Abidjan, Côte d'Ivoire. AIDS 2004
10. A.M. Timité-Konan P. Fassinou L. Adonis Koffy B.B. N'dja Les antirétroviraux chez l'enfant VIH positif en mileu tropical: Un bénéfice certain Arch Pediatr 9 2003 8312
11. Anonymous. Use of antiretroviral drugs in the management of HIV-infected persons. In: Dakar: ANRS/IMEA/IRD/SAA/UNAIDS/PNLS Sénégal/PNLS CI, IAS; 2000:12p
12. P. Echave J. Bille C. Audet I. Talla B. Vaudaux M. Gehri Percentage, bacterial etiology and antibiotic susceptibility of acute respiratory infection and pneumonia among children in rural Senegal J Trop Pediatr 49 2003 28-32
13. S.M. Graham HIV and respiratory infections in children Curr Opin Pulm Med 9 2003 215-220
14. World Health Organization, UNAIDS. Provisional WHO/UNAIDS recommendations on the use of contrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa. Afr Health Sci 2001; 1: 30-31
15. C. Chintu V. Mudenda S. Lucas et al. Lung diseases at necropsy in African children dying from respiratory illnesses: A descriptive necropsy study Lancet 360 2002 985-990
16. N.A. Ansari A.H. Kombe T.A. Kenyon et al. Pathology and causes of death in a series of Human Immunodeficiency Virus-positive and negative pediatric referral hospital admissions in Bostwana Pediatr Infect Dis J 22 2003 43-47
17. G. Kawo K. Karlsson E. Lyamuya et al. Prevalence of HIV type 1 infection, associated clinical features and mortality among hospitalized children in Dar es Salaam, Tanzania Scand J Infect Dis 32 2000 357-363
18. F. Rouet C. Montcho C. Rouzioux et al. Early diagnosis of paediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay AIDS 15 2001 1849-1856
19. Centers for Disease Control and Prevention. 1994 revised classification systems for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994; 43: (NORR 12): 1-19
20. G. Djomand T. Roels T. Euerbrock et al. Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Côte d'Ivoire AIDS 17 Suppl 3 2003 S5-S16